Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169,649 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial.
Kaabi NA, Yang YK, Zhang J, Xu K, Liang Y, Kang Y, Su JG, Yang T, Hussein S, ElDein MS, Shao S, Yang SS, Lei W, Gao XJ, Jiang Z, Wang H, Li M, Mekki HM, Zaher W, Mahmoud S, Zhang X, Qu C, Liu DY, Zhang J, Yang M, Eltantawy I, Xiao P, Wang ZN, Yin JL, Mao XY, Zhang J, Liu N, Shen FJ, Qu L, Zhang YT, Yang XM, Wu G, Li QM. Kaabi NA, et al. Among authors: zhang yt, zhang j, zhang x. Signal Transduct Target Ther. 2022 Jun 6;7(1):172. doi: 10.1038/s41392-022-00984-2. Signal Transduct Target Ther. 2022. PMID: 35665745 Free PMC article. Clinical Trial.
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial.
Kaabi NA, Yang YK, Du LF, Xu K, Shao S, Liang Y, Kang Y, Su JG, Zhang J, Yang T, Hussein S, ElDein MS, Yang SS, Lei W, Gao XJ, Jiang Z, Cong X, Tan Y, Wang H, Li M, Mekki HM, Zaher W, Mahmoud S, Zhang X, Qu C, Liu DY, Zhang J, Yang M, Eltantawy I, Hou JW, Lei ZH, Xiao P, Wang ZN, Yin JL, Mao XY, Zhang J, Qu L, Zhang YT, Yang XM, Wu G, Li QM. Kaabi NA, et al. Among authors: zhang yt, zhang j, zhang x. Nat Commun. 2022 Jun 27;13(1):3654. doi: 10.1038/s41467-022-31379-0. Nat Commun. 2022. PMID: 35760812 Free PMC article. Clinical Trial.
An engineered bispecific human monoclonal antibody against SARS-CoV-2.
Li Z, Li S, Zhang G, Peng W, Chang Z, Zhang X, Fan Z, Chai Y, Wang F, Zhao X, Li D, Zhang R, He Z, Zou W, Xu K, Lei W, Liu P, Hao J, Zhang J, Sun L, Wu G, Tan S, Gao GF, Gao F, Wu Y. Li Z, et al. Among authors: zhang r, zhang g, zhang j, zhang x. Nat Immunol. 2022 Mar;23(3):423-430. doi: 10.1038/s41590-022-01138-w. Epub 2022 Feb 28. Nat Immunol. 2022. PMID: 35228696
[Transformation of production mode and innovation of production technology of decoction pieces of Chinese crude drugs-feasibility study on intelligent production of decoction pieces of Chinese crude drugs].
Zhang C, Li L, Liu Y, Wang Y, Zhang X, Zhang J, Xiao YQ. Zhang C, et al. Among authors: zhang j, zhang x. Zhongguo Zhong Yao Za Zhi. 2018 Nov;43(21):4352-4355. doi: 10.19540/j.cnki.cjcmm.20180927.003. Zhongguo Zhong Yao Za Zhi. 2018. PMID: 30583640 Chinese.
[Analysis of misdiagnosis for 1 cases suspected diphtheria].
Zhang X, Mao WR, Zhang DY, Tang T, Yu H. Zhang X, et al. Among authors: zhang dy. Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jan;33(1):126-7. Zhonghua Liu Xing Bing Xue Za Zhi. 2012. PMID: 23002465 Chinese. No abstract available.
Human Rickettsia felis infections in Mainland China.
Teng Z, Zhao N, Ren R, Zhang X, Du Z, Wang P, Qin T. Teng Z, et al. Among authors: zhang x. Front Cell Infect Microbiol. 2022 Sep 23;12:997315. doi: 10.3389/fcimb.2022.997315. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36211956 Free PMC article.
169,649 results
You have reached the last available page of results. Please see the User Guide for more information.